HANSOH PHARMACEUTICAL GROUP COMPANY LIMITED

Governance Hansoh Pharmaceutical Group Company Limited

3692

KYG549581067

Pharmaceuticals

Market Closed - Hong Kong S.E. Other stock markets 08:08:14 17/03/2026 GMT			5-day change	1st Jan Change
32.82 ^HKD	+1.30%		-3.87%	-9.04%

03-06	Top pharma companies racing to launch a weight-loss pill	RE
03-02	Hansoh Pharmaceutical's Application for Lung Cancer Drug Accepted in China	MT

Executive Committee: Hansoh Pharmaceutical Group Company Limited

Manager

Positions heldSince

Hui Juan Zhong

65 year

Chief Executive Officer	01/12/2015
Founder	01/12/2015

Sheng Li Zhong

58 year

Corporate Secretary

31/07/2018

Leong Yin Lee

37 year

Corporate Secretary

25/12/2025

Composition of the Board of Directors: Hansoh Pharmaceutical Group Company Limited

Director

CommitteesSince

Hui Juan Zhong

65 year

Compensation Committee	01/12/2015
Nominating Committee Chair	22/12/2021

Dong Tao Yang

69 year

Audit Committee	07/10/2021
Governance Committee	27/06/2021
Compensation Committee Chair	30/05/2019
Compensation Committee	20/08/2024
Nominating Committee	20/08/2024
Nominating Committee Chair

Jia Yan

54 year

Audit Committee	25/12/2025
Nominating Committee	08/12/2020
Compensation Committee Chair	08/12/2020
Compensation Committee	28/02/2022

Sheung Wai Chan

72 year

Compensation Committee	30/01/2021
Nominating Committee	30/01/2021
Audit Committee Chair	30/01/2021
Governance Committee	27/06/2021

Guo Qiang Lin

83 year

Audit Committee	30/05/2019
Compensation Committee	30/05/2019
Nominating Committee	30/05/2019

Ai Feng Lyu

49 year

Governance Committee Chair

27/06/2021

Yu An Sun

39 year

Director/Board Member

01/12/2015

Latest Appointments: Hansoh Pharmaceutical Group Company Limited

12-28	Hansoh Pharmaceutical Group Company Limited Announces Board and Committee Composition Changes, Effective December 28, 2025	CI
24/01/25	Hansoh Pharmaceutical Group Company Limited Announces Changes to Company Secretary	CI
29/04/24	Hansoh Pharmaceutical Group Company Limited Announces Executive Changes, Effective April 29, 2024	CI
23/12/21	Hansoh Pharmaceutical Group Company Limited Announces Board Appointments	CI
06/09/21	Hansoh Pharmaceutical Group Company Limited Announces Resignation of Ma Cuifang as Non-Executive Director	CI

More news

Former Officers and Directors: Hansoh Pharmaceutical Group Company Limited

Insider

Positions held

SinceUntil

Yuen Ki Wong

Corporate Secretary

23/01/2025

25/12/2025

Yan Wing Li

Corporate Secretary

28/04/2024

Cui Fang Ma

Director/Board Member

10/03/2016

05/09/2021

Yao Chang Xu

Corporate Officer/Principal

29/02/2012

29/02/2016

Pik Yuk Cheng

Corporate Secretary

Age distribution of managers

Parity Men Women

Male	6
Female	3

Of which Executive Committee

Male	1
Female	2

Of which Directors

Male	5
Female	2

Revisions

Recommandations analystes

Évolution recommandations analystes 1 an

Évolution recommandations analystes 4 mois

Objectif analystes

Évolution objectif analystes 1 an

Évolution objectif analystes 4 mois

ESG MSCI

Environnement

Social

Gouvernance

Polémique

Controverses Ethiques

Controverses sur les droits de l'Homme

Controverses Subventions fiscales

Conforme à la finance Islamique

Hansoh Pharmaceutical Group Company Ltd is an investment holding company primarily engaged in the research and development, production and sale of a series of pharmaceutical products. The Companyâ€™s innovative drug products include Ameile, Hansoh Xinfu, Mailingda, Fulaimei, Hengmu, XINYUE, Saint Luolai and other products. The Companyâ€™s drug products are mainly used in oncology, anti-infective diseases, central nervous system (CNS) diseases, metabolic diseases and other therapeutic areas. The Company mainly conducts its business in the domestic market.

Employees

9,313

Sector

Pharmaceuticals

More about the company